Medical News

RSS

Muscular Dystrophy Association awards $14.1M in new grants

The Muscular Dystrophy Association, which has invested almost $39 million in 2010 in worldwide research seeking treatments and cures for muscle diseases, today announced that it has awarded $14.1 million in new grants.

20 Aug 2010

Schwarzenegger announces Calif. health IT network plan

Los Angeles Times: California Governor Arnold Schwarzenegger unveiled a high-tech vision for his state Tuesday, including an unprecedentedly broad computer network. "Schwarzenegger joined U.S. Chief Technology Officer Aneesh Chopra at the UC Davis Cancer Center on Tuesday to announce the launch of the country's largest 'telehealth' system, which organizers say will one day connect patients to hundreds of hospitals and clinics statewide using broadband technology." The broadband network will be devoted entirely to the health care sector (Hennessy-Fiske, 8/18).

20 Aug 2010

FDA grants priority review designation of BENLYSTA for systemic lupus erythematosus treatment

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has granted a priority review designation to BENLYSTA (belimumab) as a potential treatment for systemic lupus erythematosus.

20 Aug 2010

Bioniche provides update on Urocidin clinical development program for non-muscle-invasive bladder cancer

Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today provided an update on the clinical development program for its proprietary product for non-muscle-invasive bladder cancer - Urocidin.

20 Aug 2010

Cetero Research expands Clinical Dermatology and Transdermal Delivery System services

Cetero Research, the leading early stage contract research organization (CRO), today announced the expansion of multiple Clinical Dermatology and Transdermal Delivery System (TDDS) services to four Cetero clinical facilities.

20 Aug 2010

Gilead receives Notice Letter of Sigmapharm's ANDA submission for generic Hepsera

Gilead Sciences, Inc. today announced receipt of a Paragraph IV Certification Notice Letter advising that Sigmapharm Laboratories, LLC submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Hepsera® (adefovir dipivoxil).

20 Aug 2010

Chelsea Therapeutics announces new investigator to conduct phase II clinical study of Droxidopa

Chelsea Therapeutics International, Ltd. announced that a new investigator-led phase II clinical study of Droxidopa, an oral synthetic precursor of norepinephrine, has been initiated in chronic fatigue syndrome (CFS).

20 Aug 2010

Quality issue roundup: J & J revamping controls; The odds for orthopedic surgery; Automatic prescription refills and patient compliance

The New York Times: Johnson & Johnson has said it will "revamp its quality controls, creating a single framework for its drug, medical device and consumer health care divisions." The move comes after the drugmaker saw a number of recalls of its medicines, such as Tylenol and Motrin, as well as probes by a congressional committee and the FDA into actions at its McNeil Consumer Healthcare subsidiary.

20 Aug 2010

Complete Genomics raises $39 million in Series E funding

Complete Genomics announced today that it has raised $39 million in its Series E funding round. New investor Sands Capital led this round of financing and was joined by existing investors Essex Woodlands, OVP Venture Partners, Prospect Venture Partners, OrbiMed Advisors, Highland Capital and Enterprise Partners.

20 Aug 2010

Study reports uneven decline of colorectal cancer mortality rate

Black patients die from colorectal cancer at much higher rates than whites do and new research points to unequal health care as the cause. While deaths from colorectal cancer have declined over the past 40 years, the declines have been uneven, said lead author Samir Soneji, Ph.D., of the Robert Wood Johnson Health and Society Scholars Program at the University of Pennsylvania.

20 Aug 2010

Fenwal's new software release for Autopheresis-C system receives FDA 510(k) clearance

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market a new software release for its Autopheresis-C® system. Blood and plasma centers worldwide use the Autopheresis-C system to collect plasma from donors.

20 Aug 2010

MicroAire acquires Endotine fixation systems for facial aesthetic surgery

MicroAire Surgical Instruments is pleased to announce the acquisition of Endotine® bioabsorbable, multi-point, soft-tissue fixation systems for facial aesthetic surgery.

20 Aug 2010

FDA grants Acceleron's ACE-031 orphan designation for treatment of DMD

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the United States Food and Drug Administration (FDA) granted orphan designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in which patients experience a progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic being developed to increase muscle mass and strength.

20 Aug 2010

Metagenics announces acquisition of Catalina Lifesciences

Metagenics, Inc., a San Clemente, California-based life sciences company, today announced its acquisition of Catalina Lifesciences, Inc., the Irvine, California-based maker of Bariatric Advantage.

20 Aug 2010

KHN column: For cost control, vouchers and Medicare don't mix

In his latest Kaiser Health News column, Austin Frakt writes: "With the ambition of reducing the federal debt, Congressman Paul Ryan has offered a proposal to convert Medicare to a voucher-based program.

20 Aug 2010

Trius Therapeutics second quarter 2010 revenue increases to $2.1 million

Trius Therapeutics, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections, announced today its financial results for the three months ended June 30, 2010.

20 Aug 2010

Today's Opinions: Vouchers and Medicare; The shortage of doctors; Eliminating health system's disparities; Protecting cancer patients

With the ambition of reducing the federal debt, Congressman Paul Ryan has offered a proposal to convert Medicare to a voucher-based program. … Though rarely described this way, the private Medicare Advantage plans are a (voluntary) voucher system (Austin Frakt, 8/19).

20 Aug 2010

First Edition: August 19, 2010

In the news today, modest premium increases are ahead for Medicare drug plans while a survey finds that big employers expect health cost hikes in 2011.

20 Aug 2010

Donor kidneys from deceased as good as those from brain-dead: Study

According to a new study from the UK, transplanted kidneys from patients whose hearts have stopped perform just as well as those from patients who are brain-dead but still alive. The former have been earlier considered to be weaker since the heart had stopped pumping blood into them before transplant. The study was published online by the The Lancet.

20 Aug 2010

New ways to tackle diabetes

According to a new analysis from UK, a diet rich in green leafy vegetables may reduce the risk of developing diabetes. The inference was drawn from six studies which looked into fruit and vegetable intake and found that only food including spinach and cabbage was found to have a significant positive effect. The findings were published in the British Medical Journal (BMJ).

19 Aug 2010

Medical News

Muscular Dystrophy Association awards $14.1M in new grants

Schwarzenegger announces Calif. health IT network plan

FDA grants priority review designation of BENLYSTA for systemic lupus erythematosus treatment

Bioniche provides update on Urocidin clinical development program for non-muscle-invasive bladder cancer

Cetero Research expands Clinical Dermatology and Transdermal Delivery System services

Gilead receives Notice Letter of Sigmapharm's ANDA submission for generic Hepsera

Chelsea Therapeutics announces new investigator to conduct phase II clinical study of Droxidopa

Quality issue roundup: J & J revamping controls; The odds for orthopedic surgery; Automatic prescription refills and patient compliance

Complete Genomics raises $39 million in Series E funding

Study reports uneven decline of colorectal cancer mortality rate

Fenwal's new software release for Autopheresis-C system receives FDA 510(k) clearance

MicroAire acquires Endotine fixation systems for facial aesthetic surgery

FDA grants Acceleron's ACE-031 orphan designation for treatment of DMD

Metagenics announces acquisition of Catalina Lifesciences

KHN column: For cost control, vouchers and Medicare don't mix

Trius Therapeutics second quarter 2010 revenue increases to $2.1 million

Today's Opinions: Vouchers and Medicare; The shortage of doctors; Eliminating health system's disparities; Protecting cancer patients

First Edition: August 19, 2010

Donor kidneys from deceased as good as those from brain-dead: Study

New ways to tackle diabetes

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News